Baseimmune, a London-based biotech leveraging deep learning AI to predict pathogen mutations for vaccine development, has raised $11.3M (approximately €10.40M) in a Series A funding round. The investment was led by new investors MSD Global Health Innovation Fund and IQ Capital, with participation from existing backers such as Hoxton Ventures,